Hyperparathyroidism due to the so-called bone hunger syndrome in prostate cancer patients.
暂无分享,去创建一个
L. Dogliotti | R. Scarpa | M. Tucci | A. Berruti | A. Angeli
[1] L. Dogliotti,et al. Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonates. , 2001, The Journal of urology.
[2] P. Pitt,et al. Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer. , 2001, The Journal of clinical endocrinology and metabolism.
[3] L. Dogliotti,et al. Pamidronate administration improves the secondary hyperparathyroidism due to “Bone hunger syndrome” in a patient with osteoblastic metastases from prostate cancer , 1997, The Prostate.
[4] R. Eastell,et al. Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. , 1996, Cancer treatment reviews.